Skip Navigation
Jon Barooshian

Jon Barooshian Quoted in Law360’s “The Insys Case Made History. Why An Exec’s Appeal May Not”

John Kapoor, founder of Insys Therapeutics, has asked the U.S. Supreme Court to appeal his conviction of unlawfully orchestrating a scheme to bribe doctors to prescribe the company’s flagship opioid drug, Subsys, to boost sales. Jon Barooshian spoke with Law360 about the current motion to the case.

“I don’t think there is any [question] that Kapoor knew what he was doing,” said Barooshian. “He knew the type of product he was selling was extremely addictive and potentially fatal.  As the manufacturer of this product, he is held to the standard of an expert.”

Continue reading “The Insys Case Made History. Why An Exec’s Appeal May Not” on the Law360 website (subscription required).

Categorized: News

Tagged In: ,

View All People ›

    To get in touch, please call us at 508-791-3511 or fill out the form below. Fields in orange are required.

    Stay Current

    Subscribe to Bowditch’s updates, alerts and programs.

    Subscribe to All


    You can also follow our Bowditch Blogs. Please subscribe for new post notifications directly on the blogs. They are easily accessible in the main navigation under the Insights+News dropdown.

    An email confirmation will be sent upon submitting this form.